BOLT
Bolt Biotherapeutics Inc

839
Loading...
Loading...
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
52

Frequently Asked Questions

What is Market Cap of Bolt Biotherapeutics Inc?
What is the 52-week high for Bolt Biotherapeutics Inc?
What is the 52-week low for Bolt Biotherapeutics Inc?
What is Bolt Biotherapeutics Inc stock price today?
What was Bolt Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Bolt Biotherapeutics Inc?
What is the Price-to-Book ratio of Bolt Biotherapeutics Inc?
What is the 50-day moving average of Bolt Biotherapeutics Inc?
How many employess does Bolt Biotherapeutics Inc has?

Latest BOLT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.